Bulletin
Investor Alert

Perrigo Co. PLC

NYS: PRGO

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Dec 6, 2021, 5:29 p.m.

/zigman2/quotes/201110862/composite

$

37.04

Change

0.00 0.00%

Volume

Volume 32,098

Quotes are delayed by 20 min

/zigman2/quotes/201110862/composite

Today's close

$ 35.79

$ 37.04

Change

+1.25 +3.49%

Day low

Day high

$36.04

$38.04

Open

52 week low

52 week high

$35.34

$50.90

Open

Geoffrey M. Parker

Presently, Geoffrey M. Parker is Executive VP, Chief Operating & Financial Officer at Tricida, Inc. Mr. Parker is also on the board of ChemoCentryx, Inc., Perrigo Co. Plc, Better Therapeutics LLC and Better Therapeutics, Inc.

Mr. Parker previously was Chief Financial Officer & Senior Vice President for Anacor, Inc., Partner at The Goldman Sachs Group, Inc., Vice President of Feibusch & Co., Inc., Chief Financial Officer & Executive Vice President at Anacor Pharmaceuticals, Inc. and Chief Business Officer of InteKrin Therapeutics, Inc.

He received an undergraduate degree from Dartmouth College and an MBA from Stanford Graduate School of Business.

Transactions

Date Shares Transaction Value
05/07/2021 2,786   Derivative/Non-derivative trans. at $42.96 per share. 119,687
05/07/2021 5,804   Derivative/Non-derivative trans. at $42.96 per share. 249,339
03/17/2021 2,500   Acquisition at $41.29 per share. 103,225
05/15/2020 2,906   Derivative/Non-derivative trans. at $52.76 per share. 153,321
05/15/2020 6,054   Derivative/Non-derivative trans. at $52.76 per share. 319,409
05/15/2019 1,907   Derivative/Non-derivative trans. at $49.55 per share. 94,492
05/15/2019 3,971   Derivative/Non-derivative trans. at $49.55 per share. 196,763
11/12/2018 3,000   Acquisition at $65.35 per share. 196,050
06/06/2018 2,048   Derivative/Non-derivative trans. at $73.22 per share. 149,955
06/06/2018 4,265   Derivative/Non-derivative trans. at $73.22 per share. 312,283
07/20/2017 246   Derivative/Non-derivative trans. at $75.51 per share. 18,576
07/20/2017 511   Derivative/Non-derivative trans. at $75.51 per share. 38,585
07/20/2017 690   Derivative/Non-derivative trans. at $75.51 per share. 52,102
07/20/2017 1,437   Derivative/Non-derivative trans. at $75.51 per share. 108,507

Officers and Executives

Mr. Murray S. Kessler
President, Chief Executive Officer & Director
Mr. Raymond P. Silcock
CFO, Principal Accounting Officer & Executive VP
Mr. Thomas M. Farrington
Chief Information Officer & Executive VP
Dr. Grainne Quinn
Chief Medical Officer & Executive Vice President
Mr. Adrian Innergård
General Manager-Northern Europe
Ms. Sharon Kochan
EVP, President-RX Pharmaceuticals
Mr. Svend D. Andersen
EVP & President-Consumer Selfcare International
Mr. Ronald C. Janish
Chief Transformation Officer
Mr. James E. Dillard
President-CSCA & Executive Vice President
Mr. Louis K. Cherico
Treasurer & Vice President
Mr. Bradley Joseph
Vice President-Global Investor Relations
Mr. Robert Willis
Chief Human Resources Officer & Executive VP
Mr. Todd W. Kingma
Secretary, Executive VP & General Counsel
Mr. Rolf Allan Classon
Chairman
Ms. Katherine C. Doyle
Independent Director
Mr. Orlando D. Ashford
Independent Director
Mr. Donal M. O'Connor
Independent Director
Mr. Geoffrey M. Parker
Independent Director
Mr. Theodore Rapp Samuels
Independent Director
Mr. Bradley A. Alford
Independent, Director
Mr. Jeffrey B. Kindler
Independent Director
Ms. Adriana Karaboutis
Independent Director
Ms. Erica L. Mann
Independent Director
Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.20%
  • /zigman2/quotes/201948298/composite BABA-5.69%
  • /zigman2/quotes/202092269/composite ENSC+36.10%
  • /zigman2/quotes/200164174/composite SNOA+74.50%
  • /zigman2/quotes/207683784/composite TIGR-10.38%
X
Powered by StockTwits
Link to MarketWatch's Slice.